NEWMARKET CORP NEU

Healthcare SIC 2860 - Industrial Organic Chemicals NAICS Manufacturing › Chemical Manufacturing › Basic Chemical Manufacturing › Other Basic Organic Chemical Manufacturing derived NYSE

NewMarket Corporation (NewMarket) (NYSE: NEU) is a holding company and is the parent company of Afton Chemical Corporation (Afton), Ethyl Corporation (Ethyl), American Pacific Corporation (AMPAC), Calca Solutions, LLC (Calca), NewMarket Services Corporation (NewMarket Services), and NewMarket Development Corporation (NewMarket Development). We acquired Calca on October 1, 2025.

Each of our subsidiaries manages its own assets and liabilities. Afton manufactures and sells petroleum additives, while Ethyl markets antiknock compounds in North America and performs contracted manufacturing and related services. AMPAC is a manufacturer of specialty materials primarily used in solid rocket motors for the aerospace and defense industries, and Calca is a producer of hydrazine products used primarily in aerospace and defense applications. NewMarket Development manages the real property that we own in Virginia. NewMarket Services provides various administrative services to NewMarket, Afton, Ethyl, AMPAC, Calca, and NewMarket Development. NewMarket Services expenses are billed to each subsidiary pursuant to services agreements between the companies.

Last close 870.60 2026-10-23
Market cap $8.01B 2026-06-30 share count
52-week range 580.03 - 981.66

Valuation FY2025 figures against the last close

P/S2.9x
P/E19.6x
P/FCF16.3x
EV/EBITDA13.2x
Dividend yield1.3%
Diluted EPS44.44

Where the revenue comes from as reported in the latest 10-K

Revenue by geography

  • United States
  • Europe, Middle East, Africa, India
  • Asia Pacific
  • Other foreign
Revenue by geography, 4 categories over 3 years. The same figures are in the table below. FY2025 United States, FY2025: 1.1B (39.2%) 39% United States Europe, Middle East, Africa, India, FY2025: 818.8M (30.0%) 30% Europe, Middle East, Africa, India Asia Pacific, FY2025: 518.5M (19.0%) 19% Asia Pacific Other foreign, FY2025: 320.6M (11.8%) 12% Other foreign FY2024 United States, FY2024: 1.1B (39.3%) 39% Europe, Middle East, Africa, India, FY2024: 786.8M (28.2%) 28% Asia Pacific, FY2024: 573.3M (20.6%) 21% Other foreign, FY2024: 330.6M (11.9%) 12% FY2023 United States, FY2023: 973M (36.1%) 36% Europe, Middle East, Africa, India, FY2023: 791.7M (29.3%) 29% Asia Pacific, FY2023: 583M (21.6%) 22% Other foreign, FY2023: 350.8M (13.0%) 13%
Region FY2025FY2024FY2023
United States $1.07B $1.10B $973.0M
Europe, Middle East, Africa, India $818.8M $786.8M $791.7M
Asia Pacific $518.5M $573.3M $583.0M
Other foreign $320.6M $330.6M $350.8M

As the company reported it, from the “Net Sales (Schedule of Net Sales by Geographical Area) (Details)” note of its latest 10-K. Every figure here has been checked against the total revenue the same filing reported. Regions are the filer's own and are not mapped onto a standard list — one company's “Americas” and another's “United States” are different areas, and making them look comparable would mean making at least one of them wrong. Slices under 1% are folded into “Other”.

Annual financial statements

Income statement

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue $2.73B$2.79B$2.70B$2.76B$2.36B$2.01B$2.19B$2.29B$2.20B$2.05B
Cost of revenue $1.87B$1.90B$1.93B$2.12B$1.81B$1.42B$1.56B$1.70B$1.56B$1.37B
Gross profit $857.4M$886.3M$772.5M$640.5M$547.7M$595.0M$629.9M$585.4M$636.4M$677.2M
R&D $132.1M$124.9M$138.0M$140.3M$144.0M$140.4M$144.5M$140.3M$146.0M$160.8M
SG&A $181.6M$171.4M$151.5M$145.1M$146.0M$142.9M$148.1M$152.4M$167.7M$161.6M
Operating income $543.7M$590.0M$483.0M$355.1M$257.8M$311.8M$337.3M$292.7M$322.7M$354.8M
Interest expense $39.7M$57.4M$37.4M$35.2M$34.2M$26.3M$29.2M$26.7M$21.9M$16.8M
Pre-tax income $560.6M$584.1M$489.0M$347.7M$247.6M$331.3M$331.6M$290.3M$315.4M$343.2M
Income tax $141.8M$121.7M$100.1M$68.2M$56.6M$60.7M$77.3M$55.6M$124.9M$99.8M
Net income $418.7M$462.4M$388.9M$279.5M$190.9M$270.6M$254.3M$234.7M$190.5M$243.4M
EPS, basic 44.4448.2240.4427.7717.7124.64————
EPS, diluted 44.4448.2240.4427.7717.7124.6422.7320.3416.0820.54
Shares, diluted (wtd. avg.) 9.4M9.6M9.6M10.0M10.8M11.0M————

Balance sheet

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents $77.6M$77.5M$111.9M$68.7M$83.3M$125.2M$144.4M$73.0M$84.2M$192.2M
Short-term investments ———$0$375.9M$0————
Receivables $422.1M$395.4M$432.3M$453.7M$391.8M$336.4M$335.8M$314.9M$335.3M$306.9M
Inventory $502.3M$505.4M$456.2M$631.4M$498.5M$401.0M$365.9M$396.3M$383.1M$311.5M
Total current assets $1.06B$1.03B$1.04B$1.19B$1.39B$898.1M$879.4M$813.4M$833.7M$836.9M
Property, plant and equipment $775.5M$735.4M$654.7M$660.0M$676.8M$665.1M$635.4M$644.1M$652.3M$503.7M
Goodwill ————————$118.0M—
Total assets $3.49B$3.13B$2.31B$2.41B$2.56B$1.93B$1.89B$1.70B$1.71B$1.42B
Accounts payable $238.4M$225.9M$231.1M$273.3M$246.1M$189.9M$178.8M$151.6M$159.4M$141.9M
Short-term debt ———$0$349.4M$0————
Total current liabilities $419.3M$374.5M$364.2M$423.9M$725.1M$312.5M$308.9M$271.3M$316.8M$294.6M
Long-term debt $883.4M$971.3M$643.6M$1.00B$789.9M$598.8M$642.9M$765.8M$597.1M$502.5M
Total liabilities $1.71B$1.67B$1.23B$1.64B$1.80B$1.17B$1.20B$1.21B$1.11B$933.2M
Retained earnings $1.67B$1.43B$1.10B$834.4M$844.4M$932.3M$843.9M$671.2M$747.6M$664.2M
Total equity $1.78B$1.46B$1.08B$762.4M$762.1M$759.8M$683.1M$489.9M$601.6M$483.3M

Cash flow

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Operating cash flow $569.0M$519.6M$576.8M$108.6M$165.3M$284.2M$337.2M$197.9M$242.8M$353.4M
Depreciation and amortisation $122.4M$117.0M$78.0M$82.3M$84.3M$84.0M$87.6M$71.8M$55.3M$44.9M
Capital expenditure $77.6M$57.3M$48.3M$56.2M$78.9M$93.3M$59.4M$74.6M$148.7M$142.9M
Investing cash flow -$291.1M-$738.8M-$48.3M$315.9M-$461.4M-$74.2M-$59.4M-$60.0M-$334.6M-$143.4M
Financing cash flow -$279.1M$185.8M-$487.6M-$439.4M$255.1M-$231.5M-$208.1M-$145.4M-$19.0M-$103.4M
Dividends paid $105.9M$95.9M$85.0M$84.3M$85.9M$83.4M$81.7M$80.4M$82.9M$75.8M
Buybacks $77.2M$31.9M$42.9M$207.5M$196.2M$101.4M$0$232.0M$26.0M$35.8M

Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001282637-26-000005.

Plot the figures US dollars

Income statement Revenue Cost of revenue Gross profit R&D SG&A Total operating expenses Operating income Interest expense Pre-tax income Income tax Net income EPS, basic EPS, diluted Shares, diluted (wtd. avg.)
Balance sheet Cash and equivalents Short-term investments Receivables Inventory Total current assets Property, plant and equipment Goodwill Other intangibles Total assets Accounts payable Short-term debt Total current liabilities Long-term debt Total liabilities Retained earnings Total equity
Cash flow Operating cash flow Depreciation and amortisation Stock-based compensation Capital expenditure Investing cash flow Financing cash flow Dividends paid Buybacks
  • Revenue
  • Gross profit
  • Net income
Revenue, Gross profit, Net income by fiscal year, in US dollars The same figures are in the table below this chart. 0 1B 2B 3B Revenue, FY2016: 2B Gross profit, FY2016: 677.2M Net income, FY2016: 243.4M Revenue, FY2017: 2.2B Gross profit, FY2017: 636.4M Net income, FY2017: 190.5M Revenue, FY2018: 2.3B Gross profit, FY2018: 585.4M Net income, FY2018: 234.7M Revenue, FY2019: 2.2B Gross profit, FY2019: 629.9M Net income, FY2019: 254.3M Revenue, FY2020: 2B Gross profit, FY2020: 595M Net income, FY2020: 270.6M Revenue, FY2021: 2.4B Gross profit, FY2021: 547.7M Net income, FY2021: 190.9M Revenue, FY2022: 2.8B Gross profit, FY2022: 640.5M Net income, FY2022: 279.5M Revenue, FY2023: 2.7B Gross profit, FY2023: 772.5M Net income, FY2023: 388.9M Revenue, FY2024: 2.8B Gross profit, FY2024: 886.3M Net income, FY2024: 462.4M Revenue, FY2025: 2.7B Gross profit, FY2025: 857.4M Net income, FY2025: 418.7M FY2016 FY2017 FY2018 FY2019 FY2020 FY2021 FY2022 FY2023 FY2024 FY2025
Fiscal year FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue $2.05B $2.20B $2.29B $2.19B $2.01B $2.36B $2.76B $2.70B $2.79B $2.73B
Gross profit $677.2M $636.4M $585.4M $629.9M $595.0M $547.7M $640.5M $772.5M $886.3M $857.4M
Net income $243.4M $190.5M $234.7M $254.3M $270.6M $190.9M $279.5M $388.9M $462.4M $418.7M

Recent filings and events

  • Other event The catch-all. The company chose to disclose something that fits no other item, so the content is whatever it says it is. Item 8.01
  • Results announced The quarterly or annual earnings release. Arrives four times a year from almost every company here. Item 2.02
  • Shareholder vote The results of the annual meeting or a special vote. Item 5.07
  • Other event Item 8.01
  • Results announced Item 2.02
  • Officer or director change Someone at the top arrived or left. The item covers everything from a board retirement to a chief executive being removed, and only the filing itself says which. Item 5.02
  • Other event Item 8.01
  • Officer or director change Item 5.02
  • Annual report filed A new 10-K. The figures and the business description on this site come from it. Form 10-K
  • Results announced Item 2.02
  • Officer or director change Item 5.02
  • Officer or director change Item 5.02

Item numbers are Form 8-K's own, and a filing date is up to four business days after the thing it reports. The same feed across the whole market.

Others in SIC 2860

TickerCompanyMarket capP/ERevenue growth
IFF INTERNATIONAL FLAVORS & FRAGRANCES INC $24.02B — -5.2%
LYB LyondellBasell Industries N.V. $21.47B — -9.7%
WLK WESTLAKE CORP $8.25B — -8.0%
SXT SENSIENT TECHNOLOGIES CORP $5.65B 42.0x 3.5%
REX REX AMERICAN RESOURCES Corp $1.32B 15.9x 1.2%
GPRE Green Plains Inc. $979.9M — 16.0%
WLKP Westlake Chemical Partners LP $745.5M — 2.7%
GEVO Gevo, Inc. $286.8M — 849.3%